Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 EPS of ($1.00), $0.03 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.